InvestmentsOct 1 2014

Octopus Investments acquires MedicX

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by

Octopus Investments has acquired MedicX Holdings and its team, the UK healthcare real estate investment manager, from Cabot Square Capital

The acquisition takes Octopus’s funds under management to just over £4.7bn. MedicX manages £900m worth of funds and two private closed-ended funds.

The MedicX investment trust has proved popular with multi-managers, including Architas’s Caspar Rock and F&C Investments’ multi-manager team led by Gary Potter and Rob Burdett.

Simon Rogerson, chief executive officer at Octopus, said: “MedicX is an impressive company led by the talented management team that is well positioned to take advantage of the growth opportunities in the healthcare sector as we broaden our investment platform.”

The team is led by chief executive Mike Adams.

“This is an exciting opportunity to combine two of the leading teams in the healthcare investment sector,” he said.

“The UK faces a number of significant challenges in this area. There is plenty of evidence to illustrate the urgent need for investment if the UK is going to be able to tackle this challenge head on.”